Document is current

Any future updates will be listed below

545 BND-67: a novel immunotherapy targeting the CD28/PD-1 axis in T cells to overcome cancer resistance and transform relapse into long-term remission

Crossref DOI link: https://doi.org/10.1136/jitc-2024-SITC2024.0545

Published Online: 2024-11-05

Published Print: 2024-11

Update policy: https://doi.org/10.1136/crossmarkpolicy

About CrossMark